» Articles » PMID: 18031996

Mortality in Schizophrenia and Schizoaffective Disorder: an Olmsted County, Minnesota Cohort: 1950-2005

Overview
Journal Schizophr Res
Specialty Psychiatry
Date 2007 Nov 23
PMID 18031996
Citations 59
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Increased mortality in people with schizophrenia, compared to the general population, has been consistently reported worldwide. This mortality has been attributed predominantly to "unnatural" deaths-suicide, accidents, and homicide. Recent studies have shown an increase in natural causes of death. Our objective is to compare the mortality of schizophrenic and schizoaffective subjects to the general US population.

Methods: 319 Olmsted County residents meeting DSM-IV-TR criteria for schizophrenia or schizoaffective disorder seen at the Mayo Clinic between 1950 and 1980 were followed until February 2005 for a median of 23.5 years.

Results: At the end of follow-up, 44% of patients were deceased. Mortality was significantly (p<0.001) increased compared to the Caucasian population in the US for persons of like age, gender, and calendar year of birth. The median survival following diagnosis was 36.2 years. Death certificate cited cause of death was cardiac (29%), cancer--including lung (19%), and pulmonary disease (17%). Concerningly, there was no association with the year of diagnosis to survival.

Conclusions: Tsuang and colleagues showed in 1975 that mortality in schizophrenics and later, those with schizoaffective disorder was significantly increased compared to the US general population. Thirty years later, with a demographically similar population, we have found the same pattern of increased mortality. In light of continued improvements in the general population's lifespan, the survival gap in schizophrenia/schizoaffective disorder appears to be increasing.

Citing Articles

A Case of Risperidone-Induced Urinary Incontinence.

Eierman A, Reischman A, Gouthro R Cureus. 2024; 16(4):e58590.

PMID: 38765431 PMC: 11102709. DOI: 10.7759/cureus.58590.


Rest-activity rhythm disruption and metabolic health in schizophrenia: a cross-sectional actigraphy study of community-dwelling people living with schizophrenia and nonpsychiatric comparison participants.

Mahmood Z, Ramsey A, Kidambi N, Hernandez A, Palmer H, Liu J J Clin Sleep Med. 2024; 20(9):1505-1516.

PMID: 38661656 PMC: 11367713. DOI: 10.5664/jcsm.11192.


Factors associated with suicide attempts in the antecedent illness trajectory of bipolar disorder and schizophrenia.

Miola A, Gardea-Resendez M, Ortiz-Orendain J, Nunez N, Ercis M, Coombes B Int J Bipolar Disord. 2023; 11(1):38.

PMID: 38063942 PMC: 10709261. DOI: 10.1186/s40345-023-00318-3.


Impact of the mental health reform in Israel on health care and mortality among people with severe mental illness.

Gal G, Levav I, Kodesh A Soc Psychiatry Psychiatr Epidemiol. 2023; 59(7):1227-1234.

PMID: 37831080 DOI: 10.1007/s00127-023-02580-3.


Racial differences in pathways to care preceding first episode mania or psychosis: a historical cohort prodromal study.

Gardea-Resendez M, Ortiz-Orendain J, Miola A, Salgado M, Ercis M, Coombes B Front Psychiatry. 2023; 14:1241071.

PMID: 37732076 PMC: 10507622. DOI: 10.3389/fpsyt.2023.1241071.